amfAR, The Foundation for AIDS Research
Your membership gift will fund critical research that is helping end both the HIV and COVID-19 pandemics as quickly as possible. Please join us today.
A potentially groundbreaking clinical trial will test a combination HIV cure strategy.
Close to $350,000 awarded in first grants from the amfAR Fund to Fight COVID-19.
New research shows that factors linked to structural racism put Latino communities at elevated risk for COVID-19.
While we remain firmly committed to curing HIV, amfAR is applying its experience and expertise to the fight against COVID-19.
Millett, amfAR VP and Director of Public Policy, delivered the opening plenary at this year’s virtual International AIDS Conference.
Study shows that primarily white counties in the U.S. have the fewest cases of COVID-19 irrespective of geographic region, political inclination or before/after re-opening the economy.
amfAR assesses GBV service availability during COVID-19 lockdown in South Africa.
After pressure from advocates, people with HIV are no longer barred from COVID-19 vaccine trial.
We are constantly gathering new information to keep you up to date on the intersection between HIV and COVID-19. The hard-won lessons of HIV research are informing the race to find effective treatments and a vaccine for COVID-19.
amfAR-funded HIV researcher Dr. Dan Barouch of Harvard Medical School talks to amfAR’s Dr. Rowena Johnston about his team’s efforts to rapidly develop a safe and effective vaccine against the coronavirus.
Benefit amfAR While You Shop on AmazonIf you shop at AmazonSmile, you can benefit amfAR with every purchase—at no cost to you!
© 2020 amfAR All Rights Reserved || amfAR's mission is to end the global AIDS epidemic through innovative research